Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mladen Solar"'
Publikováno v:
Therapeutic Advances in Urology, Vol 10 (2018)
Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer. As clear differences in efficacy, safety, or tolerability between
Externí odkaz:
https://doaj.org/article/a0b0fdfdce564c538007b71111893ffa
Publikováno v:
Critical Care Medicine. 15:591-594
Multifocal atrial tachycardia (MAT) is a difficult arrhythmia to treat. Pharmacologic treatment is generally disappointing, and successful conversion in a predictable manner is uncommon. To assess the efficacy of metoprolol, a relatively selective be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce446898b7a36f32e086795cb7e64fc
https://doi.org/10.1097/00003246-198706000-00010
https://doi.org/10.1097/00003246-198706000-00010
Publikováno v:
Therapeutic Advances in Urology, Vol 9 (2017)
Background: There are two slow-release ready-to-use forms of leuprorelin acetate (1-month and 3-month) that are available as solid, biodegradable implants for the treatment of advanced, hormone-sensitive prostate cancer. These implants have been show
Externí odkaz:
https://doaj.org/article/bee2797cba3f43b099ef599cdae09349
Autor:
Victor Guadagnino, Alvin Greengart, Jacob Shani, Mladen Solar, Edgar Lichstein, Gerald Hollander
Publikováno v:
Journal of clinical pharmacology. 27(5)
This report describes two patients who received verapamil because of supraventricular arrhythmias. The patients both developed severe hypotension and signs of left ventricular compromise. The hypotension and left ventricular compromise were promptly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318a910a21c9e673585654ecc9d2f065
https://pubmed.ncbi.nlm.nih.gov/3693586
https://pubmed.ncbi.nlm.nih.gov/3693586
Publikováno v:
The American journal of medicine. 85(4)
Multifocal atrial tachycardia is a difficult arrhythmia to treat. Patients not showing a response to the correction of predisposing conditions present a therapeutic dilemma. To assess the efficacy of two agents reported to be effective in this condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d3b296e77a6f4698afe69dd35c4c1b
https://pubmed.ncbi.nlm.nih.gov/3052051
https://pubmed.ncbi.nlm.nih.gov/3052051